 | • レポートコード：MRC2-11QY05404 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はDPP IV阻害剤（DPP-4阻害剤）のグローバル市場について調査・分析したレポートです。種類別（シタグリプチン、ビルダグリプチン、サクサグリプチン、リナグリプチン、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別DPP IV阻害剤（DPP-4阻害剤）の競争状況、市場シェア ・世界のDPP IV阻害剤（DPP-4阻害剤）市場：種類別市場規模 2015年-2020年（シタグリプチン、ビルダグリプチン、サクサグリプチン、リナグリプチン、その他） ・世界のDPP IV阻害剤（DPP-4阻害剤）市場：種類別市場規模予測 2021年-2026年（シタグリプチン、ビルダグリプチン、サクサグリプチン、リナグリプチン、その他） ・世界のDPP IV阻害剤（DPP-4阻害剤）市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界のDPP IV阻害剤（DPP-4阻害剤）市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米のDPP IV阻害剤（DPP-4阻害剤）市場分析：米国、カナダ ・ヨーロッパのDPP IV阻害剤（DPP-4阻害剤）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのDPP IV阻害剤（DPP-4阻害剤）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のDPP IV阻害剤（DPP-4阻害剤）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのDPP IV阻害剤（DPP-4阻害剤）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca、Boehringer、Eli Lilly、Merck、Mitsubishi Tanabe Pharma、Novartis、Takeda ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
DPP IV inhibitors are a class of hypoglycemic agents that block the enzyme named dipeptidyl peptidase IV. Dipeptidyl peptidase IV enzyme break down the proteins that are responsible for stimulating the insulin producing cells that slows down gastric secretion. Proteins can activate the release of insulin and can control the blood sugar level if DPP IV is inhibited in our body.
Geographically, North America and Europe dominates the global market for DPP IV inhibitors due to high prevalence rate and rising awareness among people about the DPP IV inhibitors. Asia-Pacific is considered as a fastest growing market due to increasing obese population.
Market Analysis and Insights: Global DPP IV Inhibitors (DPP-4 Inhibitors) Market
The global DPP IV Inhibitors (DPP-4 Inhibitors) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global DPP IV Inhibitors (DPP-4 Inhibitors) Scope and Market Size
DPP IV Inhibitors (DPP-4 Inhibitors) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global DPP IV Inhibitors (DPP-4 Inhibitors) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the DPP IV Inhibitors (DPP-4 Inhibitors) market is segmented into
Sitagliptin
Vildagliptin
Saxagliptin
Linagliptin
Others
Segment by Application, the DPP IV Inhibitors (DPP-4 Inhibitors) market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The DPP IV Inhibitors (DPP-4 Inhibitors) market is analysed and market size information is provided by regions (countries).
The key regions covered in the DPP IV Inhibitors (DPP-4 Inhibitors) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and DPP IV Inhibitors (DPP-4 Inhibitors) Market Share Analysis
DPP IV Inhibitors (DPP-4 Inhibitors) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in DPP IV Inhibitors (DPP-4 Inhibitors) business, the date to enter into the DPP IV Inhibitors (DPP-4 Inhibitors) market, DPP IV Inhibitors (DPP-4 Inhibitors) product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca
Boehringer
Eli Lilly
Merck
Mitsubishi Tanabe Pharma
Novartis
Takeda
…
1 Study Coverage
1.1 DPP IV Inhibitors (DPP-4 Inhibitors) Product Introduction
1.2 Market Segments
1.3 Key DPP IV Inhibitors (DPP-4 Inhibitors) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Growth Rate by Type
1.4.2 Sitagliptin
1.4.3 Vildagliptin
1.4.4 Saxagliptin
1.4.5 Linagliptin
1.4.6 Others
1.5 Market by Application
1.5.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size, Estimates and Forecasts
2.1.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue 2015-2026
2.1.2 Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales 2015-2026
2.2 Global DPP IV Inhibitors (DPP-4 Inhibitors), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global DPP IV Inhibitors (DPP-4 Inhibitors) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global DPP IV Inhibitors (DPP-4 Inhibitors) Competitor Landscape by Players
3.1 DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Manufacturers
3.1.1 DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Manufacturers (2015-2020)
3.1.2 DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Manufacturers (2015-2020)
3.2 DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Manufacturers
3.2.1 DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Manufacturers (2015-2020)
3.2.2 DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by DPP IV Inhibitors (DPP-4 Inhibitors) Revenue in 2019
3.2.5 Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 DPP IV Inhibitors (DPP-4 Inhibitors) Price by Manufacturers
3.4 DPP IV Inhibitors (DPP-4 Inhibitors) Manufacturing Base Distribution, Product Types
3.4.1 DPP IV Inhibitors (DPP-4 Inhibitors) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers DPP IV Inhibitors (DPP-4 Inhibitors) Product Type
3.4.3 Date of International Manufacturers Enter into DPP IV Inhibitors (DPP-4 Inhibitors) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size by Type (2015-2020)
4.1.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Type (2015-2020)
4.1.2 Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Type (2015-2020)
4.1.3 DPP IV Inhibitors (DPP-4 Inhibitors) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Forecast by Type (2021-2026)
4.2.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Type (2021-2026)
4.2.2 Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast by Type (2021-2026)
4.2.3 DPP IV Inhibitors (DPP-4 Inhibitors) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size by Application (2015-2020)
5.1.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Application (2015-2020)
5.1.2 Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Application (2015-2020)
5.1.3 DPP IV Inhibitors (DPP-4 Inhibitors) Price by Application (2015-2020)
5.2 DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Forecast by Application (2021-2026)
5.2.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Application (2021-2026)
5.2.2 Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast by Application (2021-2026)
5.2.3 Global DPP IV Inhibitors (DPP-4 Inhibitors) Price Forecast by Application (2021-2026)
6 North America
6.1 North America DPP IV Inhibitors (DPP-4 Inhibitors) by Country
6.1.1 North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Country
6.1.2 North America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America DPP IV Inhibitors (DPP-4 Inhibitors) Market Facts & Figures by Type
6.3 North America DPP IV Inhibitors (DPP-4 Inhibitors) Market Facts & Figures by Application
7 Europe
7.1 Europe DPP IV Inhibitors (DPP-4 Inhibitors) by Country
7.1.1 Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Country
7.1.2 Europe DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe DPP IV Inhibitors (DPP-4 Inhibitors) Market Facts & Figures by Type
7.3 Europe DPP IV Inhibitors (DPP-4 Inhibitors) Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) by Region
8.1.1 Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Region
8.1.2 Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Market Facts & Figures by Type
8.3 Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Market Facts & Figures by Application
9 Latin America
9.1 Latin America DPP IV Inhibitors (DPP-4 Inhibitors) by Country
9.1.1 Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Country
9.1.2 Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Market Facts & Figures by Type
9.3 Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) by Country
10.1.1 Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Country
10.1.2 Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Market Facts & Figures by Type
10.3 Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Market Facts & Figures by Application
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca DPP IV Inhibitors (DPP-4 Inhibitors) Products Offered
11.1.5 AstraZeneca Related Developments
11.2 Boehringer
11.2.1 Boehringer Corporation Information
11.2.2 Boehringer Description and Business Overview
11.2.3 Boehringer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Boehringer DPP IV Inhibitors (DPP-4 Inhibitors) Products Offered
11.2.5 Boehringer Related Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Description and Business Overview
11.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly DPP IV Inhibitors (DPP-4 Inhibitors) Products Offered
11.3.5 Eli Lilly Related Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description and Business Overview
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck DPP IV Inhibitors (DPP-4 Inhibitors) Products Offered
11.4.5 Merck Related Developments
11.5 Mitsubishi Tanabe Pharma
11.5.1 Mitsubishi Tanabe Pharma Corporation Information
11.5.2 Mitsubishi Tanabe Pharma Description and Business Overview
11.5.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mitsubishi Tanabe Pharma DPP IV Inhibitors (DPP-4 Inhibitors) Products Offered
11.5.5 Mitsubishi Tanabe Pharma Related Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Description and Business Overview
11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis DPP IV Inhibitors (DPP-4 Inhibitors) Products Offered
11.6.5 Novartis Related Developments
11.7 Takeda
11.7.1 Takeda Corporation Information
11.7.2 Takeda Description and Business Overview
11.7.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Takeda DPP IV Inhibitors (DPP-4 Inhibitors) Products Offered
11.7.5 Takeda Related Developments
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca DPP IV Inhibitors (DPP-4 Inhibitors) Products Offered
11.1.5 AstraZeneca Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 DPP IV Inhibitors (DPP-4 Inhibitors) Market Estimates and Projections by Region
12.1.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Regions 2021-2026
12.1.2 Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast by Regions 2021-2026
12.2 North America DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Forecast (2021-2026)
12.2.1 North America: DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast (2021-2026)
12.2.2 North America: DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast (2021-2026)
12.2.3 North America: DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Forecast by Country (2021-2026)
12.3 Europe DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Forecast (2021-2026)
12.3.1 Europe: DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast (2021-2026)
12.3.2 Europe: DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast (2021-2026)
12.3.3 Europe: DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Forecast by Region (2021-2026)
12.5 Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Forecast (2021-2026)
12.5.1 Latin America: DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast (2021-2026)
12.5.2 Latin America: DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast (2021-2026)
12.5.3 Latin America: DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key DPP IV Inhibitors (DPP-4 Inhibitors) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 DPP IV Inhibitors (DPP-4 Inhibitors) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. DPP IV Inhibitors (DPP-4 Inhibitors) Market Segments
Table 2. Ranking of Global Top DPP IV Inhibitors (DPP-4 Inhibitors) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Sitagliptin
Table 5. Major Manufacturers of Vildagliptin
Table 6. Major Manufacturers of Saxagliptin
Table 7. Major Manufacturers of Linagliptin
Table 8. Major Manufacturers of Others
Table 9. Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Regions 2015-2020 (K Units)
Table 12. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Regions (2015-2020)
Table 13. Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Share by Manufacturers (2015-2020)
Table 16. Global DPP IV Inhibitors (DPP-4 Inhibitors) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global DPP IV Inhibitors (DPP-4 Inhibitors) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DPP IV Inhibitors (DPP-4 Inhibitors) as of 2019)
Table 18. DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers DPP IV Inhibitors (DPP-4 Inhibitors) Price (2015-2020) (USD/Unit)
Table 21. DPP IV Inhibitors (DPP-4 Inhibitors) Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers DPP IV Inhibitors (DPP-4 Inhibitors) Product Type
Table 23. Date of International Manufacturers Enter into DPP IV Inhibitors (DPP-4 Inhibitors) Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Type (2015-2020) (K Units)
Table 26. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Share by Type (2015-2020)
Table 27. Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Type (2015-2020) (US$ Million)
Table 28. Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Share by Type (2015-2020)
Table 29. DPP IV Inhibitors (DPP-4 Inhibitors) Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Application (2015-2020) (K Units)
Table 31. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Share by Application (2015-2020)
Table 32. North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Country (2015-2020) (K Units)
Table 33. North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Country (2015-2020)
Table 34. North America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Country (2015-2020) (US$ Million)
Table 35. North America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Country (2015-2020)
Table 36. North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Type (2015-2020) (K Units)
Table 37. North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Type (2015-2020)
Table 38. North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Application (2015-2020) (K Units)
Table 39. North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Application (2015-2020)
Table 40. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Country (2015-2020) (K Units)
Table 41. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Country (2015-2020)
Table 42. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Country (2015-2020)
Table 44. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Type (2015-2020) (K Units)
Table 45. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Type (2015-2020)
Table 46. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Application (2015-2020) (K Units)
Table 47. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Region (2015-2020) (K Units)
Table 49. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Type (2015-2020) (K Units)
Table 53. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Application (2015-2020) (K Units)
Table 55. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Application (2015-2020)
Table 56. Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Country (2015-2020) (K Units)
Table 57. Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Country (2015-2020)
Table 60. Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Type (2015-2020) (K Units)
Table 61. Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Type (2015-2020)
Table 62. Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Application (2015-2020) (K Units)
Table 63. Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Country (2015-2020) (K Units)
Table 65. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Type (2015-2020) (K Units)
Table 69. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Application (2015-2020) (K Units)
Table 71. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Application (2015-2020)
Table 72. AstraZeneca Corporation Information
Table 73. AstraZeneca Description and Major Businesses
Table 74. AstraZeneca DPP IV Inhibitors (DPP-4 Inhibitors) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 75. AstraZeneca Product
Table 76. AstraZeneca Recent Development
Table 77. Boehringer Corporation Information
Table 78. Boehringer Description and Major Businesses
Table 79. Boehringer DPP IV Inhibitors (DPP-4 Inhibitors) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Boehringer Product
Table 81. Boehringer Recent Development
Table 82. Eli Lilly Corporation Information
Table 83. Eli Lilly Description and Major Businesses
Table 84. Eli Lilly DPP IV Inhibitors (DPP-4 Inhibitors) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Eli Lilly Product
Table 86. Eli Lilly Recent Development
Table 87. Merck Corporation Information
Table 88. Merck Description and Major Businesses
Table 89. Merck DPP IV Inhibitors (DPP-4 Inhibitors) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Merck Product
Table 91. Merck Recent Development
Table 92. Mitsubishi Tanabe Pharma Corporation Information
Table 93. Mitsubishi Tanabe Pharma Description and Major Businesses
Table 94. Mitsubishi Tanabe Pharma DPP IV Inhibitors (DPP-4 Inhibitors) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Mitsubishi Tanabe Pharma Product
Table 96. Mitsubishi Tanabe Pharma Recent Development
Table 97. Novartis Corporation Information
Table 98. Novartis Description and Major Businesses
Table 99. Novartis DPP IV Inhibitors (DPP-4 Inhibitors) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Novartis Product
Table 101. Novartis Recent Development
Table 102. Takeda Corporation Information
Table 103. Takeda Description and Major Businesses
Table 104. Takeda DPP IV Inhibitors (DPP-4 Inhibitors) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Takeda Product
Table 106. Takeda Recent Development
Table 107. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Regions (2021-2026) (K Units)
Table 108. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share Forecast by Regions (2021-2026)
Table 109. Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 110. Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share Forecast by Regions (2021-2026)
Table 111. North America: DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Country (2021-2026) (K Units)
Table 112. North America: DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Europe: DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Country (2021-2026) (K Units)
Table 114. Europe: DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Asia Pacific: DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Region (2021-2026) (K Units)
Table 116. Asia Pacific: DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 117. Latin America: DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Country (2021-2026) (K Units)
Table 118. Latin America: DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Middle East and Africa: DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Country (2021-2026) (K Units)
Table 120. Middle East and Africa: DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 122. Key Challenges
Table 123. Market Risks
Table 124. Main Points Interviewed from Key DPP IV Inhibitors (DPP-4 Inhibitors) Players
Table 125. DPP IV Inhibitors (DPP-4 Inhibitors) Customers List
Table 126. DPP IV Inhibitors (DPP-4 Inhibitors) Distributors List
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. DPP IV Inhibitors (DPP-4 Inhibitors) Product Picture
Figure 2. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Type in 2020 & 2026
Figure 3. Sitagliptin Product Picture
Figure 4. Vildagliptin Product Picture
Figure 5. Saxagliptin Product Picture
Figure 6. Linagliptin Product Picture
Figure 7. Others Product Picture
Figure 8. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. DPP IV Inhibitors (DPP-4 Inhibitors) Report Years Considered
Figure 13. Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size 2015-2026 (US$ Million)
Figure 14. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales 2015-2026 (K Units)
Figure 15. Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Region (2015-2020)
Figure 17. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Region in 2019
Figure 18. Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Region (2015-2020)
Figure 19. Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Region in 2019
Figure 20. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by DPP IV Inhibitors (DPP-4 Inhibitors) Revenue in 2019
Figure 22. DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Type (2015-2020)
Figure 24. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Type in 2019
Figure 25. Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Type (2015-2020)
Figure 26. Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Type in 2019
Figure 27. Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Price Range (2015-2020)
Figure 28. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Application (2015-2020)
Figure 29. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Application in 2019
Figure 30. Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Application (2015-2020)
Figure 31. Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Application in 2019
Figure 32. North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Country in 2019
Figure 35. North America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Country in 2019
Figure 36. U.S. DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Type in 2019
Figure 41. North America DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Application in 2019
Figure 42. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Country in 2019
Figure 45. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Country in 2019
Figure 46. Germany DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 49. France DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Type in 2019
Figure 57. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Application in 2019
Figure 58. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Region in 2019
Figure 61. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Region in 2019
Figure 62. China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 63. China DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 69. India DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Type in 2019
Figure 85. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Application in 2019
Figure 86. Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Country in 2019
Figure 89. Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Country in 2019
Figure 90. Mexico DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Type in 2019
Figure 97. Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Application in 2019
Figure 98. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Country in 2019
Figure 101. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Country in 2019
Figure 102. Turkey DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Type in 2019
Figure 109. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Application in 2019
Figure 110. North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
αグルコシダーゼ阻害剤の世界市場（～2026年） Alpha-glucosidase is an enzyme that is inhibited by alpha-glucosidase inhibitor drugs. Alpha-glucosidase helps in absorption of carbohydrates by breaking down carbohydrates into tiny sugar molecules such as glucose. The inhibition is reversible, and competitive inhibition. Alpha-glucosidase inhibito…- インターロイキン阻害剤の世界市場（～2026年） Interleukin (IL) are group of cytokines that are synthesized by lymphocytes, monocytes, macrophages, and other cells. They regulate cell growth, cell differentiation, and cell motility. Fifteen different types of interleukin are present in body. Interleukin inhibitors are immunosuppressive agents th…
- 腐食・スケール抑制剤の世界市場（～2026年） Corrosion and scale inhibitors are special kind of chemicals used to prevent or control corrosion or scale formation in metals. The corrosion inhibitors segment accounted for the major shares of the cooling water treatment chemicals market. Factors such as the wide usage of corrosion inhibitors to p…
- PCSK9阻害剤の世界市場（～2026年） Market Analysis and Insights: Global PCSK9 Inhibitors Market The global PCSK9 Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global PCSK9 Inhibitors Scope and Market Size PCSK9 Inhibitors market is segmented by Ty…
- 腐食防止剤の世界市場（～2026年） Corrosion inhibitor is a chemical compound that, when added to a liquid or gas, decreases the corrosion rate of a material, typically a metal or an alloy. Market Analysis and Insights: Global Corrosion Inhibitors Market The global Corrosion Inhibitors market size is projected to reach US$ 6931.6 mil…